MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE

sirin g., ŞENTÜRK Ö., ÇELEBİ A., YILMAZ H., sezikli m., HÜLAGÜ S.

23 rd United European Gastroenterology Week, 24 - 28 Ekim 2015

  • Yayın Türü: Bildiri / Özet Bildiri
  • Kocaeli Üniversitesi Adresli: Evet